MedTrace Logo

The Incidence and the Risk Factors of Nephrocalcinosis in Very Preterm Infants

NCT04382976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2021-12-23

No results posted yet for this study

Summary

The study aims to assess the incidence and the risk factors of nephrocalcinosis in very preterm infants using patient data collected during hospitalisation at the Neonatology Centre.

Conditions

  • Nephrocalcinosis
  • Preterm Infant

Sponsors & Collaborators

  • Vilnius University

    lead OTHER

Principal Investigators

  • Rasa Garunkstiene, PhD · Vilnius University

Eligibility

Min Age
23 Weeks
Max Age
31 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-10-01
Completion
2021-10-01

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04382976 on ClinicalTrials.gov